Research in Infectious Disease and Hospital Epidemiology
The research interests of the Division include a combination of basic science, laboratory outcomes and clinical studies. Specific investigations include the study of the epidemiology and treatment of antibiotic resistant Staphylococcus aureus, outcomes and new therapies for HIV/AIDS, and epidemiology and development of rapid and specific testing and new treatments for fungal infections in immune compromised patients.
The Infectious Disease Research (IDR) Laboratory is configured for molecular infectious disease research and clinical testing. The staff is comprised of research assistants, senior laboratory technologists, and a Ph.D. Current research interests are centered around surveillance of antimicrobial resistance in patients and food animals, evaluation of proprietary antimicrobial surfactants for infection control practices, molecular speciation of fungal isolates for determination of improved treatment modalities, molecular evaluation of reduced echinocandin susceptibility in Candida sp., Human papilloma virus screening in HIV infected individuals, antiviral resistance in acute Hepatitis B virus infection, evaluation of cellular apoptotic signals relevant to Raltegravir therapy and molecular signaling pathways involved in exogenous interleukin-2 therapy in the treatment of HIV.